icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022
 Back grey_arrow_rt.gif
 
 
 
Real-World Treatment Outcome with Protease Inhibitor (PI) vs Non-PI Direct Acting Antivirals (DAAs) in advanced HCV Cirrhosis: A REAL-C study
 
 
  AASLD 2022 nov 4-8

1128221

1128222

1128223

1128224

1128225

1128226

1128227

1128228